This report offers direct evidence that the high expression of Ebp1 correlates with the presence of prostate cancer as well as a double marker combination that includes Ebp1 that can help predict PSA relapse following radical prostatectomy. The gene discussed is PA2G4; the disease is Familial prostate cancer.